IRBM, AACR

IRBM divulgará forte eficácia antitumoral de novos agentes pré-clínicos contra tumores cerebrais agressivos e leucemia linfoblástica aguda na AACR

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

IRBM S.p.A. United Kingdom United States of America France Germany Spain Italy California

en | boerse | 68001405 |